WallStSmart

Covista Inc. (CVSA)vsMynd.ai, Inc. (MYND)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 1185% more annual revenue ($1.95B vs $152.03M). CVSA leads profitability with a 12.9% profit margin vs -29.8%. CVSA earns a higher WallStSmart Score of 68/100 (B-).

CVSA

Strong Buy

68

out of 100

Grade: B-

Growth: 8.0Profit: 7.5Value: 7.0Quality: 6.5
Piotroski: 4/9Altman Z: 3.05

MYND

Avoid

26

out of 100

Grade: F

Growth: 2.7Profit: 4.0Value: 5.0Quality: 3.3
Piotroski: 2/9Altman Z: -3.96

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA5 strengths · Avg: 8.4/10
Altman Z-ScoreHealth
3.0510/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.988/10

Growing faster than its price suggests

P/E RatioValuation
17.1x8/10

Attractively priced relative to earnings

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

EPS GrowthGrowth
43.2%8/10

Earnings expanding 43.2% YoY

MYND1 strengths · Avg: 10.0/10
Return on EquityProfitability
109.4%10/10

Every $100 of equity generates 109 in profit

Areas to Watch

CVSA0 concerns · Avg: 0/10

No major concerns identified

MYND4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$18.81M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Revenue GrowthGrowth
-17.8%2/10

Revenue declined 17.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on Altman Z-Score, PEG Ratio, P/E Ratio. PEG of 0.98 suggests the stock is reasonably priced for its growth.

Bull Case : MYND

The strongest argument for MYND centers on Return on Equity.

Bear Case : CVSA

No major red flags identified for CVSA, but monitor valuation.

Bear Case : MYND

The primary concerns for MYND are EPS Growth, Market Cap, Piotroski F-Score.

Key Dynamics to Monitor

CVSA profiles as a value stock while MYND is a turnaround play — different risk/reward profiles.

MYND carries more volatility with a beta of 4.19 — expect wider price swings.

CVSA is growing revenue faster at 9.7% — sustainability is the question.

CVSA generates stronger free cash flow (97M), providing more financial flexibility.

Bottom Line

CVSA scores higher overall (68/100 vs 26/100). Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Mynd.ai, Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

MYnd Analytics, Inc. is a predictive analytics company primarily in the United States. The company is headquartered in Mission Viejo, California.

Visit Website →

Want to dig deeper into these stocks?